comparemela.com

StockNews.com downgraded shares of CEL-SCI (NYSEAMERICAN:CVM – Get Rating) from a hold rating to a sell rating in a report released on Sunday. Separately, EF Hutton Acquisition Co. I reaffirmed a buy rating and issued a $10.00 price target on shares of CEL-SCI in a report on Thursday, March 9th. CEL-SCI Price Performance NYSEAMERICAN CVM […]

Related Keywords

,Renaissance Technologies ,Millennium Management ,A Davidson ,Goldman Sachs Group Inc ,Company Profile ,Ef Hutton Acquisition Co ,Walleye Capital ,Da Davidson ,Get Rating ,Sachs Group ,Leukocyte Interleukin ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.